K. Lorentz

Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase

J. Hubbell, H. Henry, Stephan Kontos, 2015, Science Advances.

Scanning laser ophthalmoscope-particle tracking method to assess blood velocity during hypoxia and hyperoxia.

A. Zayas-Santiago, K. Lorentz, J. K. Kang Derwent, 2008, Advances in experimental medicine and biology.

Human Kunitz-type protease inhibitor engineered for enhanced matrix retention extends longevity of fibrin biomaterials.

J. Hubbell, P. Frey, P. Briquez, 2017, Biomaterials.

Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164

Mikaël M. Martino, J. Hubbell, H. Redl, 2014, Proceedings of the National Academy of Sciences.

Engineered aprotinin for improved stability of fibrin biomaterials.

J. Hubbell, P. Frey, Stephan Kontos, 2011, Biomaterials.

Engineered insulin-like growth factor-1 for improved smooth muscle regeneration.

J. Hubbell, P. Frey, K. Lorentz, 2012, Biomaterials.

Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction

J. Hubbell, J. Roberts, A. Dunaif, 2021, Science Immunology.

Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses

J. Hubbell, Erica Budina, R. Marlin, 2023, Nature Biomedical Engineering.